Combined chrysotherapeutic agents for autoimmune diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4657763
SERIAL NO

06772057

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Lysosomal enzymes and superoxide radicals (O.sub.2.sup.-) are potent mediators of rheumatoid inflammation. It is known that gold sodium thiosulphate (GTS), an injectable gold compound, inhibits lysosomal enzymes activity without however affecting its release, whereas auranofin (AF), an oral gold compound, inhibits such release but not enzyme activity. And while AF inhibits the generation of O.sub.2.sup.-, GTS is without significant effect. It has been discovered, using O.sub.2.sup.-production as an indicator of respiratory burst, that subtherapeutic concentrations of the oral gold having only partial inhibitory activity on O.sub.2.sup.- production, give rise to greatly enhanced inhibitory activity in such production when the oral gold is functionally combined with the otherwise inactive injectable gold. The effect of this combination of drugs is synergistic in that it far exceeds the sum of the individual inhibitory activities of the oral and injectable gold compounds. A further increase in O.sub.2.sup.- production inhibition is realized by adding to the combination of gold compounds hydroxychoroquine, an anti-malarial agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EBERT MICHAELNEW YORK NY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Finkelstein, Abraham E Buenos Aires, AR 1 20

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation